top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hCD16A/hNKP46 mice(CB-17 SCID)
Strain Name

CB17/lcr-PrkdcscidFcgr4tm2(FCGR3A)Bcgen

Ncr1tm1(NCR1)Bcgen/Bcgen  

Common Name  B-hCD16A/hNKP46 mice(CB-17 SCID)
Background CB-17 SCID Catalog number 112987
Related Genes 

CD16, FCG3, CD16A, FCGR3, IGFR3, IMD20, FCR-10, 

FCRIII, FCGRIII, FCRIIIA, LY94, CD335, NKP46, NK-p46

NCBI Gene ID
246256, 17086
Protein expression analysis in spleen-NKP46

from clipboard

Strain specific NKP46 expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse NKP46 antibody (eBioscience™, 17-3351-82) and anti-human NKP46 antibody (Biolegend, 331916) by flow cytometry. Mouse NKP46 was only detectable in wild-type CB-17 SCID mice. Human NKP46 was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in blood-NKP46

from clipboard

Strain specific NKP46 expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse NKP46 antibody (eBioscience™, 17-3351-82) and anti-human NKP46 antibody (Biolegend, 331916) by flow cytometry. Mouse NKP46 was only detectable in wild-type CB-17 SCID mice. Human NKP46 was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in bone marrow-NKP46

from clipboard

Strain specific NKP46 expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse NKP46 antibody (eBioscience™, 17-3351-82) and anti-human NKP46 antibody (Biolegend, 331916) by flow cytometry. Mouse NKP46 was only detectable in wild-type CB-17 SCID mice. Human NKP46 was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in spleen NK cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was only detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in spleen DC cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was only detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in spleen monocytes-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was only detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in spleen neutrophils-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was only detectable in wild-type CB-17 SCID mice. Human CD16A was not detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID).

Protein expression analysis in blood NK cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in blood DC cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in blood monocytes-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was weakly detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in blood macrophages-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was not detectable in wild-type CB-17 SCID mice. Human CD16A was weekly detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in blood neutrophils-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was not detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID).

Protein expression analysis in bone marrow NK cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was not detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in bone marrow DC cells-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was weakly detectable in wild-type CB-17 SCID mice. Human CD16A was weakly detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID).

Protein expression analysis in bone marrow monocytes-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in bone marrow macrophages-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was exclusively detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID), but not in wild-type CB-17 SCID mice.

Protein expression analysis in bone marrow neutrophils-CD16A

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) by flow cytometry. Bone marrow were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (H/H) (n=3, 6-week old). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in wild-type CB-17 SCID mice. Human CD16A was not detectable in homozygous B-hCD16A/hNKP46 mice(CB-17 SCID).

Frequency of leukocyte subpopulations in spleen, blood and bone marrow

from clipboard

Frequency of leukocyte subpopulations in spleen by flow cytometry. Splenocytes (A), blood (B) and bone marrow (C) were isolated from wild-type CB-17 SCID mice and homozygous B-hCD16A/hNKP46 mice(CB-17 SCID) (n=3, 7-week-old). Flow cytometry analysis was performed to assess the frequency of leukocyte subpopulations. Percentages of NK cells, DCs, monocytes, macrophages and neutrophils in B-hCD16A/hNKP46 mice(CB-17 SCID) were similar to those in CB-17 SCID mice, demonstrating that humanization of CD16A and NKP46 does not change the frequency or distribution of these cell types in spleen, blood and bone marrow. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test.  *P < 0.05, **P < 0.01, ***P < 0.001.